一二三区在线播放国内精品自产拍,亚洲欧美久久夜夜综合网,亚洲福利国产精品合集在线看,香蕉亚洲一级国产欧美

  • 首頁(yè) > 期刊介紹

    Current Trauma Reports

    評(píng)價(jià)信息: 加入收藏

    影響因子:1.5

    年發(fā)文量:18

    當(dāng)前創(chuàng)傷報(bào)告 SCIE

    Current Trauma Reports

    《當(dāng)前創(chuàng)傷報(bào)告》(Current Trauma Reports)是一本以CRITICAL CARE MEDICINE綜合研究為特色的國(guó)際期刊。該刊由Springer Nature出版商刊期4 issues per year。該刊已被國(guó)際重要權(quán)威數(shù)據(jù)庫(kù)SCIE收錄。期刊聚焦CRITICAL CARE MEDICINE領(lǐng)域的重點(diǎn)研究和前沿進(jìn)展,及時(shí)刊載和報(bào)道該領(lǐng)域的研究成果,致力于成為該領(lǐng)域同行進(jìn)行快速學(xué)術(shù)交流的信息窗口與平臺(tái)。該刊2023年影響因子為1.5。CiteScore指數(shù)值為1.8。

    投稿咨詢 加急發(fā)表

    期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間:

    aims: The Goal Of This Journal Is To Provide Concentrated, Evidence-based Information In The Field Of Trauma Through Authoritative Reviews. It Has Become Almost Impossible For The Average Physician To Keep Up With The Flood Of Information That Is Published In Numerous Medical Journals Or The Internet. Original Articles, Although Often Important Or Even Ground-breaking, Have Typically A Narrow Focus And On Occasions Lack Scientific Rigor. Whereas Physicians Are Encouraged To Spend The Necessary Time Reviewing Critically The Methodology And Results Of An Original Article, Their Fast-paced Professional Lives Allow Limited Opportunities To Do So. Therefore, The Need For Thoughtful, Well-constructed, And Comprehensive Reviews Has Increased In Our Times More Than Ever Before. Our New Journal Intends To Do What The Average Reader Cannot Afford Doing. It Intends To Summarize The Pertinent Information, Exclude The Irrelevant Details, And Offer Thorough, Clinically-focused Reviews. We Have Summoned True Experts From Around The World To Contribute These Reviews, Based On Their Detailed Analysis Of The Literature And Rich Personal Experience. We Hope That This Information Will Be Readily Useable And Help Shape The Practice Of Those Who Read It.

    scope: Our Journal Is About Trauma. It Will Include Every Possible Blunt Or Penetrating Traumatic Injury In Any Part Of The Body. It Will Describe Diagnostic And Therapeutic Strategies, Operative And Non-operative Alike. It Will Present Treatment Algorithms And Caution About Pitfalls And Complications. It Will Compare Outcomes, As Shown In The Literature, And Make Evidence-based Recommendations About Preferred Pathways. Besides The Strict Focus On Traumatic Diseases And Their Treatment, It Will Also Expand On Broader Issues Related To Injury Prevention And Rehabilitation. All In All, We Expect That The Scope Of The Journal Will Cover Everything That Has To Do With Trauma.

    目的:本期刊的目標(biāo)是通過權(quán)威評(píng)論提供創(chuàng)傷領(lǐng)域的集中、循證信息。普通醫(yī)生幾乎不可能跟上眾多醫(yī)學(xué)期刊或互聯(lián)網(wǎng)上發(fā)布的大量信息。原創(chuàng)文章雖然往往很重要,甚至是開創(chuàng)性的,但通常關(guān)注點(diǎn)狹窄,有時(shí)缺乏科學(xué)嚴(yán)謹(jǐn)性。雖然鼓勵(lì)醫(yī)生花費(fèi)必要的時(shí)間批判性地審查原創(chuàng)文章的方法和結(jié)果,但他們快節(jié)奏的職業(yè)生涯讓他們這樣做的機(jī)會(huì)有限。因此,在我們這個(gè)時(shí)代,對(duì)深思熟慮、結(jié)構(gòu)良好、全面的評(píng)論的需求比以往任何時(shí)候都要大。我們的新期刊旨在做普通讀者無法承受的事情。它旨在總結(jié)相關(guān)信息,排除不相關(guān)的細(xì)節(jié),并提供全面的、以臨床為重點(diǎn)的評(píng)論。我們召集了來自世界各地的真正專家,根據(jù)他們對(duì)文獻(xiàn)的詳細(xì)分析和豐富的個(gè)人經(jīng)驗(yàn)來貢獻(xiàn)這些評(píng)論。我們希望這些信息能夠隨時(shí)使用,并幫助塑造讀者的實(shí)踐。

    范圍:我們的期刊是關(guān)于創(chuàng)傷的。它將包括身體任何部位可能發(fā)生的所有鈍性或穿透性創(chuàng)傷。它將描述診斷和治療策略,包括手術(shù)和非手術(shù)。它將提出治療算法并警告陷阱和并發(fā)癥。它將比較文獻(xiàn)中顯示的結(jié)果,并就首選途徑提出基于證據(jù)的建議。除了嚴(yán)格關(guān)注創(chuàng)傷疾病及其治療外,它還將擴(kuò)大與傷害預(yù)防和康復(fù)相關(guān)的更廣泛?jiǎn)栴}??偠灾覀兤谕撈诳姆秶w與創(chuàng)傷有關(guān)的所有內(nèi)容。

    如果您需要協(xié)助投稿或潤(rùn)稿服務(wù),您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年,熟悉發(fā)表政策,可為您提供一對(duì)一投稿指導(dǎo),避免您在投稿時(shí)頻繁碰壁,節(jié)省您的寶貴時(shí)間,有效提升發(fā)表機(jī)率,確保SCI檢索(檢索不了全額退款)。我們視信譽(yù)為生命,多方面確保文章安全保密,在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。

    JCR分區(qū)(2023-2024年最新版)

    JCR分區(qū)等級(jí):Q3

    按JIF指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
    學(xué)科:CRITICAL CARE MEDICINE ESCI Q3 36 / 54

    34.3%

    按JCI指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
    學(xué)科:CRITICAL CARE MEDICINE ESCI Q3 41 / 55

    26.36%

    Gold OA文章占比 研究類文章占比 文章自引率
    12.73% 77.78%
    開源占比 出版國(guó)人文章占比 OA被引用占比

    名詞解釋:JCR分區(qū)在學(xué)術(shù)期刊評(píng)價(jià)、科研成果展示、科研方向引導(dǎo)以及學(xué)術(shù)交流與合作等方面都具有重要的價(jià)值。通過對(duì)期刊影響因子的精確計(jì)算和細(xì)致劃分,JCR分區(qū)能夠清晰地反映出不同期刊在同一學(xué)科領(lǐng)域內(nèi)的相對(duì)位置,從而幫助科研人員準(zhǔn)確識(shí)別出高質(zhì)量的學(xué)術(shù)期刊。

    CiteScore 指數(shù)(2024年最新版)

    CiteScore SJR SNIP CiteScore 指數(shù)
    1.8 0.323 0.552
    學(xué)科類別 分區(qū) 排名 百分位
    大類:Medicine 小類:Surgery Q3 282 / 551

    48%

    大類:Medicine 小類:Rehabilitation Q3 83 / 161

    48%

    大類:Medicine 小類:Orthopedics and Sports Medicine Q3 198 / 321

    38%

    名詞解釋:CiteScore是基于Scopus數(shù)據(jù)庫(kù)的全新期刊評(píng)價(jià)體系。CiteScore 2021 的計(jì)算方式是期刊最近4年(含計(jì)算年度)的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。CiteScore基于全球最廣泛的摘要和引文數(shù)據(jù)庫(kù)Scopus,適用于所有連續(xù)出版物,而不僅僅是期刊。目前CiteScore 收錄了超過 26000 種期刊,比獲得影響因子的期刊多13000種。被各界人士認(rèn)為是影響因子最有力的競(jìng)爭(zhēng)對(duì)手。

    數(shù)據(jù)趨勢(shì)圖

    歷年IF值(影響因子)

    歷年引文指標(biāo)和發(fā)文量

    歷年自引數(shù)據(jù)

    免責(zé)聲明

    若用戶需要出版服務(wù),請(qǐng)聯(lián)系出版商。